SecBot SecBot

SI

SHOULDER INNOVATIONS, INC.
NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001699350 Healthcare & Medical Devices
$19.38 −0.28 (−1.42%)
Oct 26 4:00 PM ET · prev $19.66
Market cap
$411.2M
Small cap
Consensus
Buy
92% Buy or better · 12 analysts
Median target
$26.50
+37% · range $25.00–28.00
Next earnings
Nov 5
in 10 days · EPS est. −$0.49
1 year
+57.4%
from $12.31 · Oct 27
30 days
+8.0%
from $17.95
52-week range
$11.01–24.25
−20% from high · low Nov 10
Avg volume 20D
106.6K
shares / day
Short interest
630.2K
≈3.0% of shares · +50.1%
Days to cover
3.9
at average volume
Insider net
−$5.4M
3 buyers · 3 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read MIXED 6 reports · 90 days
Balance 1 bearish · 0 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 3/6 ·Next Earnings date, Nov 5, 2026
Strongest NEUTRAL Shoulder Innovations announced the limited user release of its next-generation InSet Go glenoid implant for…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • B Mar 13 3 insiders buy $78.2K at $15.04
  • S Jun 12 to Jun 15 2 days of insider sells: $374.3K by 1 insider, avg $18.71
  • R Jun 29 Shoulder Innovations refinanced its existing $15.7M Trinity Capital…
  • A Jul 28 UBS initiates
  • S Jul 30 to Aug 6 6 days of insider sells: $3.8M by 1 insider, avg $22.85
  • S Aug 17 to Aug 26 6 days of insider sells: $1.1M by 2 insiders, avg $21.71
  • S Sep 14 1 insider sell $187.7K at $18.45
  • X Sep 30 Short interest jumps 50.1% to 630.2K

Signal stack

Where each data set points today.

  • InsidersBEARISH

    3 insiders bought $78.2K at an average $15.04. 3 insiders sold $5.5M. Price is 29% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 12 added (0 new), 2 trimmed or exited.

  • AnalystsBULLISH

    11 of 12 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.430 → −$0.491 over 90 days. 0 up, 2 down in 30 days.

  • Short sellersBUILDING

    Short interest +50.1% to 630.2K shares. 3.9 days to cover, ≈3.0% of shares.

  • TrendUPTREND

    0% above its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Sep 30.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
MORGAN STANLEYTRIM117,265$2.4M
Nuveen, LLCDOUBLED37,142$753.2K
CITADEL ADVISORS LLCDOUBLED36,795$746.2K
BANK OF AMERICA CORP /DE/ADD33,929$688.1K
Bank of New York Mellon CorpADD23,628$479.2K
ROYAL BANK OF CANADATRIM15,901$322.0K
UBS Group AGDOUBLED11,212$227.4K
RHUMBLINE ADVISERSDOUBLED11,013$223.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12 analysts
Buy 92% rate it Buy or better
Strong Buy5Buy6Hold1Sell0Strong Sell0
12-month targets · 4 analysts

Price is below the lowest target. Median implies +37%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Oct 12, 2026BTIG
MAINTAIN
MAINTAINBuy
Aug 10, 2026UBS
MAINTAIN
MAINTAINBuy
Aug 7, 2026Piper Sandler
REITERATE
REITERATEOverweight
Aug 7, 2026BTIG
MAINTAIN
MAINTAINBuy
Jul 28, 2026UBS
INITIATE
INITIATEBuy
May 8, 2026Piper Sandler
REITERATE
REITERATEOverweight

Insider ledger

Form 4
$78.2K
bought · 3 insiders
$5.5M
sold · 3 insiders
+28.8%
vs their $15.04 cost
DateInsiderTypeValue
Oct 5, 2026
BUCKMAN PAUL
Director
AWARD$25.0K
Oct 5, 2026
Tansey Casey M
Director
AWARD$14.4K
Oct 5, 2026
Hykes Andrew
Director
AWARD$13.1K
Oct 5, 2026
Sidow Kevin K.
Director
AWARD$17.5K
Sep 14, 2026
Ball Robert Joseph
CEO & Executive Chairman
EXERCISE$187.3K
Sep 14, 2026
Ball Robert Joseph
CEO & Executive Chairman
SELL$187.7K
Aug 26, 2026
Gilde Healthcare Holding B.V.
10%+ Owner
SELL$27.0K
Aug 24, 2026
Gilde Healthcare Holding B.V.
10%+ Owner
SELL$15.4K

Earnings setup

Estimates
Nov 5
reports in 10 days
−$0.49
EPS estimate, this quarter
−14%
estimate change, 90 days
0↑ 2↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.49-$0.54–-$0.44+0.0%$15.5M
Next Q-$0.48-$0.52–-$0.40+0.0%$19.1M
Current FY-$1.86-$1.90–-$1.83+0.0%$68.4M
Next FY🔒 Fresh data, subscribers only
Reddit
Recent posts
r/wallstreetbets Neutral 27d ago
Super Intelligent ($SI)
1 upvotes · 0 comments
All social signals and their track records

Short side

FINRA· Sep 30, 2026
630,244
shares short
+50.1%
vs prior settlement
3.9
days to cover
≈3.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 SEC
Shoulder Innovations announced it will report its Q3 2026 results on November 5, 2026.
PRESS-RELEASE — Impact 1/10
Oct 15, 2026 Earnings
Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026
GRAND RAPIDS, Mich., Oct. 15, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations
Oct 8, 2026 SEC
Shoulder Innovations announced the limited user release of its next-generation InSet Go glenoid implant for anatomic…
8-K — Impact 3/10
Oct 5, 2026 Insider
BUCKMAN PAUL was granted 1,275 shares
Director @ $19.60 ($25.0K)
Oct 5, 2026 Insider
Tansey Casey M was granted 733 shares
Director @ $19.60 ($14.4K)
Oct 5, 2026 Insider
Hykes Andrew was granted 669 shares
Director @ $19.60 ($13.1K)
Aug 24, 2026 SEC
Two insiders at Shoulder Innovations sold a total of ~$498K in shares over a 7-day window, led by 10% owner Gilde…
CLUSTER — Impact 4/10
Jun 30, 2026 Inst.
MORGAN STANLEY — TRIM
117,265 shares ($2.4M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
SI Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Oct 15, 2026
Earnings
Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026
GRAND RAPIDS, Mich., Oct. 15, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a…
Sep 8, 2026
Press release
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
GRAND RAPIDS, Mich., Sept. 8, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical…
Sep 1, 2026
Press release
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
GRAND RAPIDS, Mich., Sept. 1, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage…
Aug 10, 2026
Press release
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer
GRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage…
Aug 6, 2026
Earnings date
SI Q2 2026 Earnings Scheduled — 2026-08-06

SecBot reports

10 filings · 3 bullish · 1 bearish · 6 neutral
All SI filing & press-release reports (10)